ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

• Building Clinical Supply Agility In A Changing Trial Landscape

  Rising trial complexity demands agile supply built on integrated operations, solid planning, and fast issue resolution. Lean teams gain from partners providing flexibility, control, and global reach.

• Bringing A Biosimilar For Oncology To Market: Injectable Packaging From Early Development To Commercialization

  While in their early-stage development of a mAb biosimilar for oncology treatment, a large biopharmaceuticals company sought a packaging recommendation: a stopper to maintain high-quality standards.

• Build A Vial-Stopper Combination Suitable For Drug Product Storage At -80°C

  This study worked to determine if the chosen vial-stopper-seal combination will remain integral while frozen at -80°C, under studied conditions, when the appropriate materials, processing, and sealing conditions are applied.

• Transforming Clinical Supply Planning From Spreadsheets To Smart Forecasting

  Streamline your clinical supply forecasting and reduce risk by moving beyond manual spreadsheets to an integrated, real-time supply management solution.

• What Are Decentralized Clinical Trials (DCTs)?

  Discover how DCTs leverage “virtual” tools, such as telemedicine, sensory-based technologies, wearable medical devices, and direct delivery of study drugs and materials to patients’ homes.

• European Clinical Supply Planning – Balancing Cost, Flexibility, And Time

  By evaluating the key parameters of a study, sponsors can identify the most effective location for packaging and distributing clinical trial supplies.

• Streamlining Clinical Supply With Advanced Automation

  Clinical trials are the backbone of pharmaceutical advancements, but they come with their own set of challenges, particularly in data management and supply chain logistics.

• IMP Labeling: EU CTR Transition Considerations

  Review current requirements as outlined by the EU Clinical Trial Regulation, supporting guidance, and three key considerations when planning IMP labeling activities for ongoing studies.

• Case Management Accelerates Shipment For SCN1A+ Dravet Syndrome Gene Therapy

  Consider this streamlined, end-to-end solution that helped safeguard study timelines and ensured that patients with urgent medical needs could receive treatment without delay.

• How Modern Software Architecture Is Revolutionizing IRT Solutions

  Explore the ways technology suppliers across the clinical trial space have begun investing in IRTs built around a microservices model capable of improving data access and visibility.